Central nervous system progression among patients with metastatic breast cancer responding to trastuzumab treatment
- 1 February 2004
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 40 (3) , 379-382
- https://doi.org/10.1016/j.ejca.2003.09.018
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Central nervous system metastases in women who receive trastuzumab‐based therapy for metastatic breast carcinomaCancer, 2003
- Clinical Activity of Trastuzumab and Vinorelbine in Women With HER2-Overexpressing Metastatic Breast CancerJournal of Clinical Oncology, 2001
- Use of Chemotherapy plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer That Overexpresses HER2New England Journal of Medicine, 2001
- High incidence of central nervous system involvement in patients with metastatic or locally advanced breast cancer treated with epirubicin and docetaxelAnnals of Oncology, 2001
- A Retrospective Study of First Indicators of Breast Cancer RecurrenceOncology, 2000
- Do anticancer agents reach the tumor target in the human brain?Cancer Chemotherapy and Pharmacology, 1992
- Cerebral metastases in patients with ovarian cancer treated with chemotherapyGynecologic Oncology, 1989
- Studies of the HER-2/ neu Proto-Oncogene in Human Breast and Ovarian CancerScience, 1989
- Central nervous system metastasis from breast carcinoma autopsy studyCancer, 1983
- The natural history of breast cancer patients with brain metastasesCancer, 1979